IP Library › Granted Patent US 10,991,456
Granted Patent B2
US 10,991,456 · App. 15/409,433 · Granted Apr 27, 2021

Method and system for determining analyte levels

Inventors: Gary Alan Hayter (Oakland, CA); Erwin Satrya Budiman (Fremont, CA)
Assignee: Abbott Diabetes Care Inc.
G16H15/00A61B5/002A61B5/14532A61B5/14546A61B5/14865A61B5/4839A61B5/6849G16H20/17G16H40/67A61B2560/0242A61B2560/0252
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,991,456
App. No.
15/409,433
Granted
Apr 27, 2021
Kind
B2
Abstract

Systems, methods, and apparatus are provided for analyte level estimation to improve accuracy thereof. Systems include sensor electronics operatively coupled to an analyte sensor configured for contact with a user's biofluid. A user interface device is configured for communication with the sensor electronics and configured to determine a predicted state estimate using exogenous measurement data and a past state estimate and, thereafter, determine a corrected state estimate, including an estimated analyte level, using the predicted state estimate and current analyte sensor measurement data.

Claims (32)

1. A system, comprising:

an analyte sensor comprising sensor electronics operatively coupled thereto and configured to be positioned in fluid contact with biofluid under a skin surface of a user;

a user interface device configured to communicate with the sensor electronics over a wireless electrical communication link, the user interface device including a processor, wherein the processor is configured to:

receive exogenous measurement data;

receive current analyte sensor measurement data from the analyte sensor;

iteratively determine a plurality of present predicted state estimates using the exogenous measurement data and a past state estimate, wherein each subsequent present predicted state estimate is provided as input as the past state estimate;

determine a present corrected state estimate using the iteratively determined plurality of present predicted state estimates and the current analyte sensor measurement data, the present corrected state estimate including an estimated analyte level; and

a medication delivery device system configured for delivery of medication to the user based on the estimated analyte level.

2. The system off claim 1 , wherein the exogenous measurement data includes at least one of: insulin delivery information, meal intake information, or exercise information.

3. The system of claim 1 , wherein at least one of the predicted state estimate or the corrected state estimate is determined using a Kalman filter.

4. The system of claim 1 , wherein the processor is further configured to use an adjustable rate variance filter to filter the exogenous measurement data.

5. The system of claim 4 , wherein the processor is further configured to adjust the rate variance filter in response to a determined insulin delivery level.

6. The system of claim 1 , wherein the biofluid under the skin surface includes interstitial fluid.

7. The system of claim 1 , wherein the exogenous measurement data is data manually received at the user interface device.

8. The system of claim 1 , wherein the analyte level is a glucose level.

9. The system of claim 1 , wherein the processor is further configured to update a medication delivery profile based on the estimated analyte level.

10. The system of claim 9 , wherein the processor is further configured to output the updated medication delivery profile using the user interface device.

11. The system of claim 9 , wherein the processor is further configured transmit the updated medication delivery profile to the medication delivery device system.

12. The system of claim 1 , wherein the analyte sensor is a continuous analyte sensor.

13. The system of claim 1 , wherein the processor is further configured to output the estimated analyte level using the user interface device.

14. A method, comprising:

receiving, by a user interface device, exogenous measurement data;

receiving, by the user interface device, current analyte sensor measurement data from an analyte sensor, the analyte sensor configured to be positioned in fluid contact with biofluid under a skin surface of a user;

iteratively determining, by the user interface device, a plurality of predicated state estimates using the exogenous measurement data and a past state estimate, wherein each subsequent present predicted state estimate is provided as input as the past state estimate;

determining, by the user interface device, a present corrected state estimate using the iteratively determined plurality of present predicted state estimates and the current analyte sensor measurement data, the present corrected state estimate including an estimated analyte level;

delivering, using a medication delivery device system, medication to the user based on the estimated analyte level.

15. The method of claim 14 , further comprising outputting the estimated analyte level to a user interface device.

16. The method of claim 14 , wherein the exogenous measurement data includes at least one of: insulin delivery information, meal intake information, or exercise information.

17. The method of claim 14 , wherein at least one of the predicted state estimate or the corrected state estimate is determined using a Kalman filter.

18. The method of claim 14 , further comprising filtering the exogenous measurement data using an adjustable rate variance filter.

19. The method of claim 14 , wherein the exogenous measurement data is data manually received at the user interface device.

20. The method of claim 14 , further comprising updating a medication delivery profile based on the estimated analyte level.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2017
From: HAYTER, GARY ALAN; BUDIMAN, ERWIN SATRYA
To: ABBOTT DIABETES CARE INC.
Reel/Frame 041431/0105 →
Continuity (5)
Continuation 13925685 · Jun 24, 2013
Continuation 13424291 · Mar 19, 2012
Continuation 12024101 · Jan 31, 2008
Provisional Application 60917873 · May 14, 2007
Related Publication 20170124287A1 · May 4, 2017
Cited By (3)
US 12,315,619 US 12,667,666 US 12,706,190